Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sterilisation device to undergo US Phase II trials:

This article was originally published in Clinica

Executive Summary

Conceptus is to begin US Phase II clinical trials of its S/TOP device for permanent contraception. The effectiveness of the selective tubal occlusion procedure device, which is deployed permanently into each fallopian tube, will be assessed in an initial study of 15 patients. The company, based in San Carlos, California, began its first Phase II clinical trial of the device at a single site in Australia last year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083320

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel